GB202214721D0 - A treatment for mental disorders - Google Patents

A treatment for mental disorders

Info

Publication number
GB202214721D0
GB202214721D0 GBGB2214721.9A GB202214721A GB202214721D0 GB 202214721 D0 GB202214721 D0 GB 202214721D0 GB 202214721 A GB202214721 A GB 202214721A GB 202214721 D0 GB202214721 D0 GB 202214721D0
Authority
GB
United Kingdom
Prior art keywords
treatment
mental disorders
mental
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2214721.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rewire Therapeutics Ltd
Original Assignee
Rewire Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rewire Therapeutics Ltd filed Critical Rewire Therapeutics Ltd
Priority to GBGB2214721.9A priority Critical patent/GB202214721D0/en
Publication of GB202214721D0 publication Critical patent/GB202214721D0/en
Priority to PCT/GB2023/052606 priority patent/WO2024074850A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2214721.9A 2022-10-06 2022-10-06 A treatment for mental disorders Pending GB202214721D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2214721.9A GB202214721D0 (en) 2022-10-06 2022-10-06 A treatment for mental disorders
PCT/GB2023/052606 WO2024074850A1 (en) 2022-10-06 2023-10-06 A treatment for mental disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2214721.9A GB202214721D0 (en) 2022-10-06 2022-10-06 A treatment for mental disorders

Publications (1)

Publication Number Publication Date
GB202214721D0 true GB202214721D0 (en) 2022-11-23

Family

ID=84818032

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2214721.9A Pending GB202214721D0 (en) 2022-10-06 2022-10-06 A treatment for mental disorders

Country Status (2)

Country Link
GB (1) GB202214721D0 (en)
WO (1) WO2024074850A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2628883T3 (en) 2006-03-24 2017-08-04 Auxilium International Holdings, Inc. Procedure for the preparation of an extruded hot melt laminate
US9687445B2 (en) 2012-04-12 2017-06-27 Lts Lohmann Therapie-Systeme Ag Oral film containing opiate enteric-release beads
NL2018190B1 (en) * 2017-01-18 2018-07-26 Procare Beheer B V Psilocybin or psilocin in combination with cannabinoid
KR20220008824A (en) * 2019-04-17 2022-01-21 컴퍼스 패쓰파인더 리미티드 How to treat anxiety disorders, headache disorders and eating disorders with psilocybin
BR112022022331A2 (en) * 2020-05-05 2022-12-20 Univ Basel METHOD TO ENHANCE POSITIVE THERAPEUTIC EFFECTS OF A PSYCHEDELIC, COMPOSITION, AND METHOD TO TREAT A PATIENT
AU2022342266A1 (en) * 2021-09-08 2024-02-01 Cybin Irl Limited Combination drug therapies

Also Published As

Publication number Publication date
WO2024074850A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
IL294594A (en) Methods for treating pemphigus disorders
SG10201911828YA (en) A medical waste treatment device
GB202214721D0 (en) A treatment for mental disorders
GB202004161D0 (en) Filter for a treatment apparatus
EP3858286C0 (en) Tool for a medical treatment
EP3858285C0 (en) Tool for a medical treatment
IL307607A (en) Tetracyclic compounds for treating brain disorders
IL288797A (en) Treatment for synucleinopathies
EP4040991A4 (en) Treatment for gastrointestinal disorders
IL280548A (en) A new medical treatment for pathologic inflammation
GB202020549D0 (en) Treatment for Lysine Degradation-associated Disorders
GB202204231D0 (en) Retinal Disorders
GB202204234D0 (en) Retinal Disorders
GB202204230D0 (en) Retinal Disorders
GB202109590D0 (en) Combination treatment for coronavirus
GB202314527D0 (en) New treatment for pain
EP4098263A4 (en) Treatment for chondrodystrophia
ZA202207243B (en) A pharmaceutical combination for the treatment of a cancer
GB202007082D0 (en) Assemblage for forming a treatment chair
GB202002038D0 (en) Compounds for treating bone disorders
IL309393A (en) Retinal disorders
IL309392A (en) Retinal disorders
IL311440A (en) A patient support platform for increasing patient engagement
GB202108760D0 (en) Retinal disorders
GB202108759D0 (en) Retinal disorders